Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that slows digestion and signals fullness to the brain. Clinical trials show average monthly weight loss ranges from 4–10 pounds, though individual results vary significantly based on dose, lifestyle, and genetic factors.

Typical Monthly Weight Loss Rates on Semaglutide

Real-world weight loss on semaglutide typically follows a pattern: most patients lose 1–2 pounds per week during active treatment, which amounts to approximately 4–8 pounds per month on average. This rate is higher in the first 4–8 weeks as the body adjusts to the medication's appetite-suppressing effects, then may stabilize or continue at a slower pace depending on dose escalation and adherence.

The STEP trials, which tested semaglutide for weight management, demonstrated that participants on the 2.4 mg maintenance dose lost an average of 15 percent of their baseline body weight over 68 weeks. Translating this to monthly progress, patients typically achieved their most dramatic results during months 2–4, with continued gradual loss through month 12 and beyond.

Individual variation is substantial—some patients report losing 10+ pounds in their first month, while others lose 2–3 pounds monthly. Starting weight, baseline metabolism, and strict adherence to the injection schedule all influence these outcomes.

Factors That Influence Your Monthly Weight Loss Results

Dose escalation directly impacts monthly weight loss. PlexusDx patients begin at lower doses and gradually increase every 4 weeks until reaching their therapeutic dose—typically 1.0–2.4 mg weekly for semaglutide injection. During dose-escalation weeks, weight loss may be modest, but accelerates once the maintenance dose takes effect. Your dose may need to go up. Your price won't.

Baseline body weight and composition matter significantly: individuals with higher starting weights often experience faster absolute pound loss in early months, though percentage loss may be similar across weight categories. Genetic factors also play a role—certain genetic variants in the GLP1R and FTO genes influence how your body responds to semaglutide, which PlexusDx explores through its Precision Peptide Genetic Test.

Lifestyle factors including diet quality, protein intake, and physical activity amplify semaglutide's effects. Patients who maintain a structured meal plan and incorporate resistance training often see 20–30 percent greater weight loss than those relying on medication alone. Consistency with weekly injections and adequate hydration also support optimal results.

How Genetic Testing Predicts Your Personal Weight Loss Response

PlexusDx's Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—markers that influence how efficiently your body processes appetite-regulating peptides. Understanding your genetic profile helps predict whether you'll respond quickly to standard semaglutide doses or benefit from alternative compounds like tirzepatide, which targets dual pathways.

Patients with genetic predispositions to strong GLP-1 receptor responsiveness frequently achieve monthly weight loss in the 8–10 pound range, while those with FTO variants linked to higher baseline appetite may see initial loss of 3–5 pounds monthly until reaching optimal dosing. This personalized insight allows PlexusDx clinicians to tailor compound selection and dosing schedules to your unique biochemistry, maximizing monthly progress and minimizing trial-and-error delays.

Expected Weight Loss Timeline: Month-by-Month Breakdown

Month 1: Many patients experience modest weight loss (2–4 pounds) during the dose-titration phase while their body adjusts to semaglutide. Appetite suppression typically becomes noticeable by week 2–3, with water weight loss contributing to early results.

Months 2–4: This period often brings the most significant monthly losses (6–10 pounds per month) as the full appetite-suppressing effects activate and patients maintain consistent dietary discipline. Metabolic adaptation begins during this window, which is why continued adherence remains critical.

Months 5–12: Weight loss typically decelerates to 2–4 pounds monthly as the body approaches a new metabolic equilibrium. This is normal physiology and does not indicate medication failure; many patients maintain this steady loss throughout treatment. Adjusting exercise intensity or dietary macros can help sustain momentum during this plateau phase.

Semaglutide vs. Other GLP-1 Options: Weight Loss Comparison

Semaglutide injection (starting at $149/month with PlexusDx) and tirzepatide (starting at $249/month) show comparable early weight loss rates—both average 4–8 pounds monthly during active titration. However, tirzepatide targets both GLP-1 and GIP pathways, which may produce slightly faster results (5–10 pounds monthly) in some patients, particularly those with genetic markers favoring dual-pathway activation.

Oral semaglutide ($249/month) achieves similar monthly weight loss as the injection form when taken correctly on an empty stomach, though gastrointestinal side effects are more common with oral delivery. PlexusDx's Microdose GLP-1 Protocol ($129/month) offers a gentler entry point for patients sensitive to standard doses, often resulting in 2–4 pounds monthly while building tolerance before escalating to higher-dose formulations.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a realistic monthly weight loss goal on semaglutide?

Expect 4–8 pounds per month on average during active treatment, with faster loss (6–10 pounds monthly) during months 2–4 and slower loss (2–4 pounds monthly) beyond month 6. Your individual rate depends on dose, adherence, genetics, and lifestyle factors. PlexusDx personalization helps optimize your expected timeline.

Does semaglutide weight loss slow down after a few months?

Yes, this is normal. Initial rapid loss reflects appetite suppression and water weight; after 8–12 weeks, the body adapts and loss typically decelerates to 2–4 pounds monthly. This plateau does not mean the medication has stopped working—it reflects metabolic equilibrium at a lower body weight. Continuing treatment prevents weight regain.

How much does semaglutide cost per month with PlexusDx?

PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing increases—your dose may need to go up, your price won't. The medication is available in all 50 states without insurance, HSA/FSA eligible, and includes optional Precision Peptide Genetic Testing ($99 add-on) to optimize your personal response.

Are there side effects that might slow weight loss?

Nausea, vomiting, and constipation are common early side effects that typically resolve within 1–2 weeks. If side effects persist and limit your ability to eat enough to maintain nutrition, speak with your PlexusDx clinician—dose adjustments or alternative compounds like tirzepatide may improve tolerability without sacrificing results.

Can genetic testing predict how much I'll lose per month?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to estimate your likelihood of rapid response versus slower, steady weight loss. Patients with favorable GLP-1 pathway genetics often lose 8–10 pounds monthly, while those needing dual-pathway activation may benefit more from tirzepatide. Testing guides compound selection for faster, personalized results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves